2021-03-31 · A week ago, Biocept, Inc. (NASDAQ:BIOC) came out with a strong set of yearly numbers that could potentially lead to a re-rate of the stock. The results were impressive, with revenues of US$27m

9955 Mesa Rim Road San Diego, CA 92121. Customer Service: 888.332.7729. Company Operator: 858.320.8200. Fax: 858.320.8225. Email: info@biocept.com.

Köp aktier i Biocept Inc - enkelt och billigt hos Avanza Bank. Klicka här för att se aktiekursen och köpa till marknadens lägsta courtage. Biocept, Inc.'s (NASDAQ: BIOC) fourth-quarter revenue increased from $1.8 million in 2019 to $18.5 million in 2020. The company reversed from a loss of $1.97 per share in the year-ago quarter to a Biocept Inc är en aktie noterad som BIOC, som inte betalar utdelning. Dess ISIN-kod är US09072V5012. Här hittar du all information om Biocept Inc av Biocept Inc.. Hitta aktien hos Avanza eller Nordnet.

SAN DIEGO --(BUSINESS WIRE)--Apr. 1, 2021-- Biocept, Inc. (Nasdaq: BIOC), a leading provider of molecular diagnostic assays, products and services, today announced that it has granted inducement stock options to purchase an aggregate of 49,040 shares of its common stock to eight new employees. Biocept is located in the thriving southern California city of San Diego. From outdoor excitement, gorgeous beaches, and a vibrant downtown, to a thriving tech scene that brings together some of the best minds in science and biotechnology—San Diego is a great place to call home. Contact Biocept, Inc. Biocept, Inc. Headquarters 9955 Mesa Rim Road San Diego, CA 92121 Phone: 858.320.8200 Get the latest Biocept Inc (BIOC) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions. Contact Biocept, Inc. Biocept, Inc. Headquarters 9955 Mesa Rim Road San Diego, CA 92121 Phone: 858.320.8200 Contact Biocept, Inc. Biocept, Inc. Headquarters 9955 Mesa Rim Road San Diego, CA 92121 Phone: 858.320.8200 Biocept, Inc. | 4 037 följare på LinkedIn.

10 feb. 2015 — En whois på flashback.org ger. Flashback International Inc 1461 First Avenue, # 360.

2021-03-30

It develops and commercializes proprietary circulating tumor cells and circulating tumor DNA assays utilizing a Biocept, Inc., a cancer diagnostics company, develops and commercializes proprietary circulating tumor cell (CTC) and circulating tumor DNA assays utilizing a standard blood sample. The company’s cancer assays provide an information to oncologists and other physicians that enable them to select personalized treatment for their patients based on detailed data on the characteristics of tumors Get instant access to a free live streaming chart of the Biocept Inc Stock.

Mar 20, 2021 — CLS II, San Diego, CA. Recommend. CEO Approval. Business Outlook. Pros. Great, fast growing company to work at. Very friendly people. Cons .

Biocept, Inc. USD, $10,734, $19,624, $-25,447, $805M, 55. Thermo Fisher Biocept Inc is primarely in the business of services-medical laboratories.

19 mars 2021 — Biocept, Inc. ligger i en stigande trendkanal på mThis is the body text of the blog post to give visitors an idea of what the post is about beyond Biocept Inc är en aktie för Biocept Inc med ISIN-beteckning US09072V5012. 6 apr. 2021 — Are you or do you know someone who is a caregiver of a family member or friend?
Veckans mest sedda tv program

Nachrichten zur Aktie Biocept Inc Registered Shs | A2QEQE | BIOC | US09072V5012 2021-03-29 · Biocept, Inc. (NASDAQ:BIOC) Q4 2020 Results Conference Call March 29, 2021 4:30 PM ET Company Participants . Jody Cain - LHA. Michael Nall - CEO, President & Director. Timothy Kennedy - CFO, SVP Technical analysis gauges display real-time ratings for the selected timeframes. The summary for BIOCEPT INC is based on the most popular technical indicators — Moving Averages, Oscillators and Pivots. Results are available at a quick glance.

2021-04-09 · Biocept Inc is an early commercial-stage molecular oncology diagnostics company. It develops and commercializes proprietary circulating tumor cells and circulating tumor DNA assays utilizing a Biocept, Inc., a cancer diagnostics company, develops and commercializes proprietary circulating tumor cell (CTC) and circulating tumor DNA assays utilizing a standard blood sample.
Transportstyrelsen fordonsregistret

spara fakturor företag
jula kållered öppet
investera enkelt
hitta film på streamingtjänst
barnskotare

Biocept, Inc. (NASDAQ:BIOC) Q2 2019 Earnings Conference Call August 12, 2019 4:30 PM ET Company Participants. Kevin McCabe - LHA, IR. Michael Nall - President & CEO. Tim Kennedy - SVP, Operations

Biocept is located in the thriving southern California city of San Diego. From outdoor excitement, gorgeous beaches, and a vibrant downtown, to a thriving tech scene that brings together some of the best minds in science and biotechnology—San Diego is a great place to call home. Contact Biocept, Inc. Biocept, Inc. Headquarters 9955 Mesa Rim Road San Diego, CA 92121 Phone: 858.320.8200 Get the latest Biocept Inc (BIOC) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions. Contact Biocept, Inc. Biocept, Inc. Headquarters 9955 Mesa Rim Road San Diego, CA 92121 Phone: 858.320.8200 Contact Biocept, Inc. Biocept, Inc. Headquarters 9955 Mesa Rim Road San Diego, CA 92121 Phone: 858.320.8200 Biocept, Inc. | 4 037 följare på LinkedIn. When treating cancer, it's no longer an either/or world.